Modulation of NF-κB activation by Peroxinitrite
Peroxinitrite (ONOO-, PN)
is formed by the reaction of nitric oxide (NO) with superoxide (O2·-)
[71], and is thus generated when the
production of NO and O2·- is enhanced, notably under
inflammatory conditions, circulatory shock and reperfusion injury [72].
PN formation also occurs in the heart during myocardial infraction [73] and heart failure [74].
PN is a highly oxidant and nitrating species causing important cellular
injuries and is associated with numerous pathologies. Recently, PN was also demonstrated to modify
redox-sensitive cellular signalling pathways, such as the NF-κB pathway. PN was shown by several authors to activate
NF-κB in endothelial cells [75], leukocytes [76] and vascular smooth muscle cells [77]. However, a recent work carried out
by Levrand et al. clearly demonstrated that PN is a potent inhibitor of
NF-κB activation triggered by inflammatory stimuli in cardiac and endothelial
cell lines [78].
They demonstrated that PN blocks IKKβ phosphorylation and activation,
thereby preventing NF-κB nuclear translocation.
The PN inhibitory effect on NF-κB activation was further confirmed by
Park et al. [79]. They showed
that PN is capable of inducing p65 tyrosine nitration on Y66 and Y152, which in
turn triggers replacement of p65/p50 dimers with the repressive p50/p50 complex
on promoters and subsequent association of p65 with IκBα to promote export [79].
Therefore, the data collected about the effects of PN on the NF-κB
pathway are apparently contradictory and still a matter of debate [80].
Post Comment
No comments